09/11/2015 - 11:05am

Repatha is one in a new class of cholesterol medications called PSCK9 (proprotein convertase substilisin kexin type 9) inhibitors, which are potentially an alternative to statins.

09/10/2015 - 2:10pm

Purdue Pharma this week announced that it had VM902A, acquired an allosteric selective tropmyosin receptor kinase A (TrkA) inhibitor, from VM Pharma.

09/10/2015 - 1:26pm

The acquisition of Diplomat's compounding pharmacy assets by Restore Health enables Diplomat to continue their singular focus on specialty pharmacy, the companies stated. 

09/10/2015 - 9:42am

A new report from the Pharmaceutical Research and Manufacturers of America is highlighting the large volume of cancer medicines and vaccines that are currently being developed, as well as the impact innovations have had on cancer death rates. 

09/03/2015 - 8:41am

 The drug, a biosimilar version of Amgen’s Neupogen, is the first biosimilar drug to launch in the U.S.

09/01/2015 - 8:46am

The company said the patch is a potential solution for the 73% of migraine sufferers who experience nausea with their migraines. 

08/25/2015 - 10:43am

Amneal Pharmaceuticals announced Tuesday that it would be opening a new biosciences unit, that will be focused on commercializing specialty pharmaceuticals. 

08/25/2015 - 10:11am

The drug can be used in children 1 year of age and older with ITP who have not had a sufficient response to a splenectomy, immunoglobulins or corticosteroids.

08/24/2015 - 4:33pm

After years of research and billions of dollars in funding, the Human Genome Project has unlocked the complex mysteries of the human genome and unleashed a new era in personalized medicine and pharmaceutical research and development. And pharmacy retailers must get out in front of that gene-based drug revolution or risk being left behind.